Insider Transactions in Q2 2025 at Guardant Health, Inc. (GH)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 30
2025
|
Steve E. Krognes Director |
BUY
Exercise of conversion of derivative security
|
Direct |
155
+1.41%
|
-
|
|
Apr 17
2025
|
Musa Tariq Director |
SELL
Open market or private sale
|
Direct |
116
-3.35%
|
$5,104
$44.79 P/Share
|
|
Apr 15
2025
|
John G. Saia Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,956
-8.43%
|
$174,064
$44.85 P/Share
|
|
Apr 15
2025
|
John G. Saia Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,568
+13.89%
|
-
|
|
Apr 15
2025
|
Musa Tariq Director |
BUY
Exercise of conversion of derivative security
|
Direct |
250
+6.74%
|
-
|
|
Apr 15
2025
|
Myrtle S Potter Director |
BUY
Exercise of conversion of derivative security
|
Direct |
68
+0.48%
|
-
|
|
Apr 04
2025
|
Meghan V. Joyce Director |
BUY
Exercise of conversion of derivative security
|
Direct |
66
+0.84%
|
-
|
|
Apr 01
2025
|
Chris Freeman Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,106
-2.55%
|
$46,452
$42.47 P/Share
|
|
Apr 01
2025
|
Chris Freeman Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,595
+4.06%
|
-
|
|
Apr 01
2025
|
Kumud Kalia Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
961
-4.29%
|
$40,362
$42.47 P/Share
|
|
Apr 01
2025
|
Kumud Kalia Chief Information Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,691
+5.81%
|
-
|
|
Apr 01
2025
|
John G. Saia Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,360
-3.34%
|
$57,120
$42.47 P/Share
|
|
Apr 01
2025
|
John G. Saia Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,641
+3.18%
|
-
|
|
Apr 01
2025
|
Darya Chudova Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,524
-2.0%
|
$64,008
$42.47 P/Share
|
|
Apr 01
2025
|
Darya Chudova Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,006
+1.96%
|
-
|
|
Apr 01
2025
|
Craig Eagle Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,295
-3.82%
|
$54,390
$42.47 P/Share
|
|
Apr 01
2025
|
Craig Eagle Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,381
+4.87%
|
-
|
|
Apr 01
2025
|
Helmy Eltoukhy Co-Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,163
-0.5%
|
$510,846
$42.47 P/Share
|
|
Apr 01
2025
|
Helmy Eltoukhy Co-Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,998
+0.98%
|
-
|
|
Apr 01
2025
|
Amir Ali Talasaz Co-Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,163
-0.52%
|
$510,846
$42.47 P/Share
|
|
Apr 01
2025
|
Amir Ali Talasaz Co-Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,998
+1.02%
|
-
|
|
Apr 01
2025
|
Michael Brian Bell Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,057
-2.55%
|
$44,394
$42.47 P/Share
|
|
Apr 01
2025
|
Michael Brian Bell Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,084
+4.79%
|
-
|